Czech National Bank Has $16.12 Million Position in Corteva, Inc. $CTVA

Czech National Bank boosted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 3.9% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 190,372 shares of the company’s stock after purchasing an additional 7,213 shares during the period. Czech National Bank’s holdings in Corteva were worth $16,123,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CTVA. Brighton Jones LLC grew its stake in shares of Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after buying an additional 11,760 shares in the last quarter. Woodline Partners LP lifted its stake in shares of Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Corteva by 62.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC boosted its holdings in Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares in the last quarter. Finally, Jump Financial LLC acquired a new position in Corteva during the second quarter worth $1,464,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of NYSE CTVA opened at $76.95 on Friday. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The company has a market cap of $51.34 billion, a P/E ratio of 50.96, a P/E/G ratio of 2.36 and a beta of 0.57. The business’s 50 day moving average is $81.93 and its two-hundred day moving average is $79.82. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. The company had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.Corteva’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the prior year, the business earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 47.68%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. CICC Research raised their target price on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. Oppenheimer increased their price objective on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. Royal Bank Of Canada raised their price objective on Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday, July 21st. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday. Finally, Mizuho increased their price target on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a report on Tuesday, July 14th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $91.70.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.